Showing results (1-10 of 790) with videos related to
Sort By:
Pageof 79
Pharmacogenomics|January 26, 2016
Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatmentLydia Wt Cheung, Gordon B MillsMolecular & Cellular Oncology|June 17, 2016
p85α neomorphic mutants: splitting away from the canonical pathLydia Wt Cheung, Gordon B MillsGenes & Diseases|April 4, 2023
Drugging IGF-1R in cancer: New insights and emerging opportunitiesPanpan Wang, Victor Cy Mak, Lydia Wt CheungNeoplasia (New York, N.Y.)|June 18, 2021
p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repairVictor Cy Mak, Xinran Li, Ling Rao, et al.Nature Communications|February 27, 2025
p85β acts as a transcription cofactor and cooperates with BCLAF1 in the nucleusPanpan Wang, Victor Cy Mak, Ling Rao, et al.Cancer Cell|March 16, 2010
The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3Gordon B Mills, Yosef YardenCancer Research|May 7, 2013
AMPK: a contextual oncogene or tumor suppressor?Jiyong Liang, Gordon B MillsThe Journal of Clinical Investigation|May 1, 2024
Enhancing anticancer activity of macrophages through rational drug combinationsGordon B Mills, Marilyne LabrieClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1Guang Peng, Gordon B MillsExpert Reviews in Molecular Medicine|October 16, 2007
Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progressionMandi Murph, Gordon B MillsPageof 79